Long‐term change of glomerular gelatinolytic activity in rats with streptozotocin‐induced diabetes

SUMMARY: In diabetic nephropathy, a decrease in the activity of matrix metalloproteinase (MMP) might contribute to the build‐up of extracellular matrix protein in the mesangium and the glomerular basement membrane (GBM). Levels of MMP activity were measured as gelatinolytic activity in glomerular homogenates isolated from rats 1, 4, 12, 24 and 48 weeks after inducing diabetes mellitus (DM) with streptozotocin. The level of glomerular gelatinolytic activity after 1 week in DM rats was significantly increased compared with that in controls (224.8% of control; DM vs. control, 13.58 vs. 6.04 mU/glomerulus; P < 0.05), then decreased by 48 weeks (week 4, 92.8% of control; week 12, 81.9% of control; week 24, 31.8% of control; week 48, 47.3% of control). Glomerular metalloproteinase migrated on gelatin zymography at positions representing molecular weights of approximately 97, 80, 70 and 65 kDa. The intensity of these lytic bands was increased at 1 week but decreased at 24 and 48 weeks. Light microscopy revealed hypercellularity in the mesangial area at 1 week, followed by mild and marked mesangial expansion with GBM thickening at 12 and 48 weeks respectively. These data suggest that the persistent decrease in glomerular gelatinolytic activity during the chronic phase contributes to mesangial expansion and GBM thickening in DM rats. Moreover, the activity may play different roles at the time of onset and during the progression of diabetic nephropathy.

[1]  A. E. El Nahas,et al.  Effects of Transforming Growth Factor-β1 on Renal Extracellular Matrix Components and Their Regulating Proteins , 1999 .

[2]  D. Yue,et al.  Competitive RT-PCR for measuring metalloproteinase gene expression in human mesangial cells exposed to a hyperglycemic environment. , 1999, BioTechniques.

[3]  G. Gambaro,et al.  Mesangial Cell Proliferation in Long-Term Streptozotocin-Induced Diabetes mellitus in the Rat and the Renoprotective Activity of Heparin , 1999, American Journal of Nephrology.

[4]  G. Striker,et al.  IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. , 1999, Diabetes.

[5]  R. Harris,et al.  Molecular Basis of Injury and Progression in Focal Glomerulosclerosis , 1999, Nephron.

[6]  Ashutosh Kumar Singh,et al.  Decreased Glomerular Proteinase Activity in the Streptozotocin Diabetic Rat , 1999, American Journal of Nephrology.

[7]  G. Striker,et al.  Glomerular endothelial cells synthesize collagens but little gelatinase A and B. , 1998, Journal of the American Society of Nephrology : JASN.

[8]  D. Yue,et al.  Effect of Glucose on Matrix Metalloproteinase Activity in Mesangial Cells , 1998, Nephron.

[9]  T. Eto,et al.  Serial Alterations of Glomerular Matrix-Degrading Metalloproteinase Activity in Anti-Thymocyte-Induced Glomerulonephritis in Rats , 1998, Nephron.

[10]  Z. Gaciong,et al.  Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. , 1997, Kidney international. Supplement.

[11]  G. Gambaro,et al.  Effect of glucose and heparin on mesangial alpha 1(IV)COLL and MMP-2/TIMP-2 mRNA expression. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  T. Eto,et al.  Neutral metalloproteinases in human urine from normal patients and renal disease patients , 1996 .

[13]  C. Nast,et al.  Expression of transforming growth factor-β isoforms in human glomerular diseases , 1996 .

[14]  Ashutosh Kumar Singh,et al.  Decreased Degradative Enzymes in Mesangial Cells Cultured in High Glucose Media , 1995, Diabetes.

[15]  C. Alpers,et al.  Cellular events in the evolution of experimental diabetic nephropathy. , 1995, Kidney international.

[16]  W. Stetler-Stevenson,et al.  Assessment of 72-kilodalton gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli. , 1994, Journal of the American Society of Nephrology : JASN.

[17]  Y. Tomino,et al.  Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. , 1994, Renal physiology and biochemistry.

[18]  J. Knowlden,et al.  Identification and independent regulation of human mesangial cell metalloproteinases. , 1994, Kidney international.

[19]  D. Yue,et al.  High Glucose Concentration Causes a Decrease in Mesangium Degradation: A Factor in the Pathogenesis of Diabetic Nephropathy , 1994, Diabetes.

[20]  J. Walcott,et al.  STZ-Induced Diabetes Results in Decreased Activity of Glomerular Cathepsin and Metalloprotease in Rats , 1993, Diabetes.

[21]  D. Lovett,et al.  Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. , 1993, The Biochemical journal.

[22]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[23]  C. Nast,et al.  Expression of transforming growth factor-beta isoforms in human glomerular diseases. , 1996, Kidney international.

[24]  L. Racusen,et al.  Glomerular metalloprotease activity in streptozotocin- treated rats and in spontaneously diabetic rats (BB/DP). , 1994, Life sciences.

[25]  A. Heidland,et al.  Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats. , 1989, American journal of nephrology.